The cerebrospinal fluid proteome in HIV infection: change associated with disease severity
<p>Abstract</p> <p>Background</p> <p>Central nervous system (CNS) infection is a nearly universal feature of untreated systemic HIV infection with a clinical spectrum that ranges from chronic asymptomatic infection to severe cognitive and motor dysfunction. Analysis of...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-03-01
|
| Series: | Clinical Proteomics |
| Subjects: | |
| Online Access: | http://www.clinicalproteomicsjournal.com/content/9/1/3 |
| _version_ | 1818807763624525824 |
|---|---|
| author | Angel Thomas E Jacobs Jon M Spudich Serena S Gritsenko Marina A Fuchs Dietmar Liegler Teri Zetterberg Henrik Camp David G Price Richard W Smith Richard D |
| author_facet | Angel Thomas E Jacobs Jon M Spudich Serena S Gritsenko Marina A Fuchs Dietmar Liegler Teri Zetterberg Henrik Camp David G Price Richard W Smith Richard D |
| author_sort | Angel Thomas E |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Central nervous system (CNS) infection is a nearly universal feature of untreated systemic HIV infection with a clinical spectrum that ranges from chronic asymptomatic infection to severe cognitive and motor dysfunction. Analysis of cerebrospinal fluid (CSF) has played an important part in defining the character of this evolving infection and response to treatment. To further characterize CNS HIV infection and its effects, we applied advanced high-throughput proteomic methods to CSF to identify novel proteins and their changes with disease progression and treatment.</p> <p>Results</p> <p>After establishing an <it>accurate mass and time </it>(AMT) tag database containing 23,141 AMT tags for CSF peptides, we analyzed 91 CSF samples by LC-MS from 12 HIV-uninfected and 14 HIV-infected subjects studied in the context of initiation of antiretroviral therapy and correlated abundances of identified proteins a) within and between subjects, b) with all other proteins across the entire sample set, and c) with "external" CSF biomarkers of infection (HIV RNA), immune activation (neopterin) and neural injury (neurofilament light chain protein, NFL). We identified a mean of 2,333 +/- 328 (SD) peptides covering 307 +/-16 proteins in the 91 CSF sample set. Protein abundances differed both between and within subjects sampled at different time points and readily separated those with and without HIV infection. Proteins also showed inter-correlations across the sample set that were associated with biologically relevant dynamic processes. One-hundred and fifty proteins showed correlations with the external biomarkers. For example, using a threshold of cross correlation coefficient (Pearson's) ≤ -0.3 and ≥0.3 for potentially meaningful relationships, a total of 99 proteins correlated with CSF neopterin (43 negative and 56 positive correlations) and related principally to neuronal plasticity and survival and to innate immunity. Pathway analysis defined several networks connecting the identified proteins, including one with amyloid precursor protein as a central node.</p> <p>Conclusions</p> <p>Advanced CSF proteomic analysis enabled the identification of an array of novel protein changes across the spectrum of CNS HIV infection and disease. This initial analysis clearly demonstrated the value of contemporary state-of-the-art proteomic CSF analysis as a discovery tool in HIV infection with likely similar application to other neurological inflammatory and degenerative diseases.</p> |
| first_indexed | 2024-12-18T19:30:50Z |
| format | Article |
| id | doaj.art-2452b4eea8dd419db39c1eaa56c68ba9 |
| institution | Directory Open Access Journal |
| issn | 1559-0275 |
| language | English |
| last_indexed | 2024-12-18T19:30:50Z |
| publishDate | 2012-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Clinical Proteomics |
| spelling | doaj.art-2452b4eea8dd419db39c1eaa56c68ba92022-12-21T20:55:44ZengBMCClinical Proteomics1559-02752012-03-0191310.1186/1559-0275-9-3The cerebrospinal fluid proteome in HIV infection: change associated with disease severityAngel Thomas EJacobs Jon MSpudich Serena SGritsenko Marina AFuchs DietmarLiegler TeriZetterberg HenrikCamp David GPrice Richard WSmith Richard D<p>Abstract</p> <p>Background</p> <p>Central nervous system (CNS) infection is a nearly universal feature of untreated systemic HIV infection with a clinical spectrum that ranges from chronic asymptomatic infection to severe cognitive and motor dysfunction. Analysis of cerebrospinal fluid (CSF) has played an important part in defining the character of this evolving infection and response to treatment. To further characterize CNS HIV infection and its effects, we applied advanced high-throughput proteomic methods to CSF to identify novel proteins and their changes with disease progression and treatment.</p> <p>Results</p> <p>After establishing an <it>accurate mass and time </it>(AMT) tag database containing 23,141 AMT tags for CSF peptides, we analyzed 91 CSF samples by LC-MS from 12 HIV-uninfected and 14 HIV-infected subjects studied in the context of initiation of antiretroviral therapy and correlated abundances of identified proteins a) within and between subjects, b) with all other proteins across the entire sample set, and c) with "external" CSF biomarkers of infection (HIV RNA), immune activation (neopterin) and neural injury (neurofilament light chain protein, NFL). We identified a mean of 2,333 +/- 328 (SD) peptides covering 307 +/-16 proteins in the 91 CSF sample set. Protein abundances differed both between and within subjects sampled at different time points and readily separated those with and without HIV infection. Proteins also showed inter-correlations across the sample set that were associated with biologically relevant dynamic processes. One-hundred and fifty proteins showed correlations with the external biomarkers. For example, using a threshold of cross correlation coefficient (Pearson's) ≤ -0.3 and ≥0.3 for potentially meaningful relationships, a total of 99 proteins correlated with CSF neopterin (43 negative and 56 positive correlations) and related principally to neuronal plasticity and survival and to innate immunity. Pathway analysis defined several networks connecting the identified proteins, including one with amyloid precursor protein as a central node.</p> <p>Conclusions</p> <p>Advanced CSF proteomic analysis enabled the identification of an array of novel protein changes across the spectrum of CNS HIV infection and disease. This initial analysis clearly demonstrated the value of contemporary state-of-the-art proteomic CSF analysis as a discovery tool in HIV infection with likely similar application to other neurological inflammatory and degenerative diseases.</p>http://www.clinicalproteomicsjournal.com/content/9/1/3AmyloidCerebrospinal fluidHIVPathwayProteomics |
| spellingShingle | Angel Thomas E Jacobs Jon M Spudich Serena S Gritsenko Marina A Fuchs Dietmar Liegler Teri Zetterberg Henrik Camp David G Price Richard W Smith Richard D The cerebrospinal fluid proteome in HIV infection: change associated with disease severity Clinical Proteomics Amyloid Cerebrospinal fluid HIV Pathway Proteomics |
| title | The cerebrospinal fluid proteome in HIV infection: change associated with disease severity |
| title_full | The cerebrospinal fluid proteome in HIV infection: change associated with disease severity |
| title_fullStr | The cerebrospinal fluid proteome in HIV infection: change associated with disease severity |
| title_full_unstemmed | The cerebrospinal fluid proteome in HIV infection: change associated with disease severity |
| title_short | The cerebrospinal fluid proteome in HIV infection: change associated with disease severity |
| title_sort | cerebrospinal fluid proteome in hiv infection change associated with disease severity |
| topic | Amyloid Cerebrospinal fluid HIV Pathway Proteomics |
| url | http://www.clinicalproteomicsjournal.com/content/9/1/3 |
| work_keys_str_mv | AT angelthomase thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT jacobsjonm thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT spudichserenas thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT gritsenkomarinaa thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT fuchsdietmar thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT lieglerteri thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT zetterberghenrik thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT campdavidg thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT pricerichardw thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT smithrichardd thecerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT angelthomase cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT jacobsjonm cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT spudichserenas cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT gritsenkomarinaa cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT fuchsdietmar cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT lieglerteri cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT zetterberghenrik cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT campdavidg cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT pricerichardw cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity AT smithrichardd cerebrospinalfluidproteomeinhivinfectionchangeassociatedwithdiseaseseverity |